|
Volumn 77, Issue 1, 2014, Pages 4-6
|
Hormone therapy in postmenopausal women and risk of endometrial hyperplasia: A Cochrane review summary
|
Author keywords
Endometrial hyperplasia; Hormone therapy; Menopause
|
Indexed keywords
ESTRADIOL;
ESTROGEN;
FOLLITROPIN;
GESTAGEN;
NORETHISTERONE ACETATE;
PLACEBO;
DOSE RESPONSE;
DRUG MEGADOSE;
DRUG WITHDRAWAL;
EDITORIAL;
ENDOMETRIAL THICKNESS;
ENDOMETRIUM BIOPSY;
ENDOMETRIUM CARCINOMA;
ENDOMETRIUM HYPERPLASIA;
ESTROGEN THERAPY;
FOLLITROPIN BLOOD LEVEL;
HORMONAL THERAPY;
HUMAN;
LOW DRUG DOSE;
MEDICATION COMPLIANCE;
POSTMENOPAUSE;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
TRANSVAGINAL ECHOGRAPHY;
TREATMENT DURATION;
VAGINA BLEEDING;
ENDOMETRIAL HYPERPLASIA;
HORMONE THERAPY;
MENOPAUSE;
ENDOMETRIAL HYPERPLASIA;
ESTROGEN REPLACEMENT THERAPY;
ESTROGENS;
FEMALE;
HUMANS;
POSTMENOPAUSE;
PROGESTINS;
RISK;
|
EID: 84891748593
PISSN: 03785122
EISSN: 18734111
Source Type: Journal
DOI: 10.1016/j.maturitas.2013.10.002 Document Type: Editorial |
Times cited : (21)
|
References (5)
|